
About Intrinsic Therapeutics
Intrinsic Therapeutics is a Healthcare company based in Woburn (United States) founded in 2000. Spinal disc reconstruction prostheses are developed to prevent reherniation. Intrinsic Therapeutics has raised $138.68 million across 8 funding rounds from investors including Credit Suisse, Greenspring Associates and CRG. Its chief executive, as recorded, is Cary Hagan. Intrinsic Therapeutics offers products and services including Barricaid Implant. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is Authentidate Holding Corp. Its competitors include Nevro, ATEC Spine and Vertos Medical; 2 of its 3 listed competitors have raised funding.
Company details
Intrinsic Therapeutics was founded in 2000 and is based in Woburn, United States. Operations focus on the medical device sector, where implantable prostheses for spinal annulus repair are produced. The Barricaid device is designed for use after limited discectomy to reinforce annular defects and lower reherniation risks. This addresses weaknesses created by nuclear material removal during surgery for disc herniation.
- Total Equity Funding$138.68M (USD)
in 8 rounds
- Latest Funding Round$28M (USD), Series D
May 2017
- InvestorsCredit Suisse
& 6 more
Products & Services of Intrinsic Therapeutics
Intrinsic Therapeutics offers a comprehensive portfolio of products and services, including Barricaid Implant.
Implant reduces reherniation risk after discectomy surgery
Apps and channels of Intrinsic Therapeutics
its YouTube channel Barricaid® has 409 subscribers and 30 videos.
Videos from Intrinsic Therapeutics
The most watched videos on Intrinsic Therapeutics's YouTube channel, Barricaid® (409 subscribers). Click a video to play it here.
More on Barricaid®.
Funding Insights of Intrinsic Therapeutics
Intrinsic Therapeutics has successfully raised a total of $138.68M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $28 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $138.68M
- Total Rounds 8
- Last Round Series D — $28M
- First Round $25M
(Jan 2003)
- Investors Count 7
All 8 funding rounds of Intrinsic Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2017 | $28M | Series D | – | New Enterprise Associates | |
| May 2017 | $21M | Debt – Venture | – | – | |
| Dec 2016 | $17.88M | Series C | – | – | – |
| Sep 2014 | $17.2M | Series C | – | – | – |
| Oct 2012 | $11.6M | Series C | – | – | – |
| Feb 2010 | $18M | Series C | – | – | – |
| Sep 2007 | $21M | Series C | – | – | |
| Jan 2003 | $25M | Series C | – | – |
7 investors in total: 7 institutional.
Investors in Intrinsic Therapeutics
Intrinsic Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, Greenspring Associates and CRG.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CRG is recognized as a premier healthcare investment partner. | crglp.com | Houston, United States | ||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Diversified investment management firm | 2000 | greenspringassociates.com | Owings Mills, United States | |
Sector-agnostic investment company making venture capital investments globally | quadrillecapital.com | Paris, France | ||
Venture capital investments are directed toward therapeutics and medtech startups. | deloscapital.com | Hong Kong, China | ||
| spraypartners.com | ||||
Wealth management, asset management, and investment banking services are offered. | 1856 | credit-suisse.com | Zurich, Switzerland |
Investor details for Intrinsic Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Intrinsic Therapeutics
1 people are tracked at Intrinsic Therapeutics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Cary Hagan | CEO & President | Leadership |
Complete people profiles for Intrinsic Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Intrinsic Therapeutics
3 dated milestones of Intrinsic Therapeutics across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Intrinsic Therapeutics is founded.
- Funding First funding round of $25.0M.
- Funding Latest funding round, Series D, of $28.0M.
Competitors of Intrinsic Therapeutics
Intrinsic Therapeutics has 3 listed competitors in our database, 2 of them funded. They include Nevro, ATEC Spine and Vertos Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nevro.com | 2006 | Menlo Park, United States | $154.1M | 1,215 | Provider of high-frequency spinal cord stimulation implants | |
| atecspine.com | 1990 | San Diego, United States | 839 | Treatment solutions for spine disorders are developed. | ||
| vertosmed.com | 2005 | Aliso Viejo, United States | $177.75M | 140 | Minimally invasive treatments for lumbar spinal stenosis are developed. |
Detailed competitors of Intrinsic Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as Intrinsic Therapeutics (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Intrinsic Therapeutics
Complete news archive for Intrinsic Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intrinsic Therapeutics
Intrinsic Therapeutics was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Intrinsic Therapeutics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Cary Hagan is the CEO of Intrinsic Therapeutics, as recorded in our data.
Intrinsic Therapeutics is a funded company, having raised a total of $138.68M across 8 funding rounds to date. The company's 1st funding round was a Series C of $25M, raised on Jan 2003.
Intrinsic Therapeutics was founded in 2000 and is based in Woburn, United States. Operations focus on the medical device sector, where implantable prostheses for spinal annulus repair are produced. The Barricaid device is designed for use after limited discectomy to reinforce annular defects and lower reherniation risks. This addresses weaknesses created by nuclear material removal during surgery for disc herniation.
Intrinsic Therapeutics's top competitors include Nevro, ATEC Spine and Vertos Medical.
Intrinsic Therapeutics offers Barricaid Implant.
Intrinsic Therapeutics has 7 investors. Key investors include Credit Suisse, Greenspring Associates, CRG, NEA, and Quadrille Capital.
Intrinsic Therapeutics operates through Authentidate Holding Corp.
